SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-100256
Filing Date
2023-09-13
Accepted
2023-09-13 08:47:15
Documents
14
Period of Report
2023-09-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2325987d1_8k.htm   iXBRL 8-K 27006
2 EXHIBIT 99.1 tm2325987d1_ex99-1.htm EX-99.1 10838
6 GRAPHIC tm2325987d1_ex99-1img001.jpg GRAPHIC 6263
  Complete submission text file 0001104659-23-100256.txt   226538

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hook-20230913.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20230913_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20230913_pre.xml EX-101.PRE 22369
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2325987d1_8k_htm.xml XML 3448
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 231251681
SIC: 2834 Pharmaceutical Preparations